Skip to main content
menu sluit menu
Home Home
Login
Main navigation
  • Library
  • Calendar
  • e-Learning
  • News
    • Veterinary News In this section you find veterinary news
    • Recent Additions All content that was recently added to the IVIS library
  • Get involved
    • Donate Support IVIS, make a donation today
    • Media kit Promote your e-learning & events on IVIS
    • Add your e-learning & events to the IVIS calendar
    • Publish on IVIS Publish your work with us
  • About
    • Mission Our Mission Statement
    • What we do More info about IVIS and what we do
    • Who we are More info about the IVIS team
    • Authors See list of all IVIS authors and editors
  • Contact
User tools menu
User tools menu
Main navigation
  • Library
  • Calendar
  • e-Learning
  • News
    • Veterinary News In this section you find veterinary news
    • Recent Additions All content that was recently added to the IVIS library
  • Get involved
    • Donate Support IVIS, make a donation today
    • Media kit Promote your e-learning & events on IVIS
    • Add your e-learning & events to the IVIS calendar
    • Publish on IVIS Publish your work with us
  • About
    • Mission Our Mission Statement
    • What we do More info about IVIS and what we do
    • Who we are More info about the IVIS team
    • Authors See list of all IVIS authors and editors
  • Contact
Follow IVIS
  • Twitter
  • Facebook
Support IVIS

Breadcrumb

  1. Home
  2. Library
  3. Encyclopedia of Canine Clinical Nutrition
  4. Lipid Metabolism
Encyclopedia of Canine Clinical Nutrition
Back to Table of Contents
Add to My Library
Close
Would you like to add this to your library?

Get access to all handy features included in the IVIS website

  • Get unlimited access to books, proceedings and journals.
  • Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
  • Bookmark your favorite articles in My Library for future reading.
  • Save future meetings and courses in My Calendar and My e-Learning.
  • Ask authors questions and read what others have to say.
Sign in Register
Comments
Print this article
Share:
  • Facebook
  • LinkedIn
  • Mail
  • Twitter

Lipid Metabolism

Author(s):
Schenck P.A.
In: Encyclopedia of Canine Clinical Nutrition by Pibot P. et al.
Updated:
APR 21, 2008
Languages:
  • DE
  • EN
  • ES
  • FR
  • IT
Back to Table of Contents
Add to My Library
Close
Would you like to add this to your library?

Get access to all handy features included in the IVIS website

  • Get unlimited access to books, proceedings and journals.
  • Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
  • Bookmark your favorite articles in My Library for future reading.
  • Save future meetings and courses in My Calendar and My e-Learning.
  • Ask authors questions and read what others have to say.
Sign in Register
Print this article
SHARE:
  • Facebook
  • LinkedIn
  • Mail
  • Twitter
    Read

    Hyperlipidemia or hyperlipemia refers to an increased cloudiness in serum due to an excess of circulating lipids. The term lipemia, the presence of lipids in serum, is often incorrectly used to describe excess circulating lipids. Hyperlipidemia and hyperlipoproteinemia are often used interchangeably, but hyperlipoproteinemia more correctly refers to an excess of circulating lipoproteins. Hypercholesterolemia and hypertriglyceridemia refer respectively to an excess of circulating cholesterol or triglyceride. Hypercholesterolemia or hypertriglyceridemia may occur alone or in combination with hyperlipoproteinemia. Normally hyperlipidemia occurs after ingesting a meal, but fasting hyperlipidemia is indicative of abnormal lipid metabolism.

    Patricia SCHENCK
    DVM, PhD

    Dr. Schenck received her Masters degree in Animal Science and her DVM degree from the University of Illinois in Champaign-Urbana. After owning her own small animal practice, she returned to the University of Florida where she completed her PhD in lipid biochemistry. After completing a post-doc at the USDA in Peoria Illinois, she joined the Ohio State University, where she became interested in research in calcium regulation. After working in the pet food industry for a number of years, she joined the Endocrinology section in the Diagnostic Center for Population and Animal Health at Michigan State University in 2001. Her current research interests include developing new tests for increasing diagnostic utility in calcium and lipid disorders, hyperlipidemias in the dog, idiopathic hypercalcemia in the cat, and the relationships between lipids and parathyroid hormone.

    1. Lipid Metabolism

    Perturbations in any aspect of lipid metabolism may result in abnormal hyperlipidemia. Abnormalities may occur in lipid absorption, synthesis, esterification, lipoprotein synthesis, receptor-mediated uptake, bile formation and circulation, or reverse cholesterol transport.

    Lipid Absorption

    Cholesterol and triglycerides are absorbed in the small intestine. Cholesterol may be ingested in the diet (exogenous), or is derived from biliary secretion and desquamation of intestinal epithelial cells (endogenous) which may account for up to 50% of the total cholesterol present in the small intestinal lumen (Holt, 1972). Absorption requires bile acids and micelle formation (Figure 1). Bile salts are secreted by the liver and enter the small intestine via the bile, and most salts exist as conjugates with glycine or taurine. When the concentration of bile salts reaches a high enough level, bile salts form aggregates or micelles (Feldman et al., 1983), and allow approximately 30 to 60% of available cholesterol to be absorbed. Within the lumen of the intestine, cholesteryl esters from micelles are hydrolyzed by pancreatic cholesterol esterase. Free cholesterol passively diffuses across the intestinal mucosal cell wall (Westergaard et al., 1976). Within the intestinal cell, free cholesterol is re-esterified with fatty acids, a process mediated by the enzyme acyl CoA:cholesterylacyltransferase (ACAT). A combination of free cholesterol and cholesteryl esters are then secreted into chylomicron particles.

    Digestion and absorption of lipids
    Figure 1. Digestion and absorption of lipids (from Gogny, 1994).

    Within the intestinal lumen, triglycerides are hydrolyzed by pancreatic lipase to mono-glycerides, diglycerides, and free fatty acids. In combination with cholesterol, phospholipid, and bile salts, these monoglycerides, diglycerides, and free fatty acids form mixed micelles. These micelles release monoglycerides, diglycerides, and free fatty acids at the intestinal cell wall where they are absorbed (Figure 1). Within the intestinal cell, monoglycerides and diglycerides are re-esterified to form triglycerides. Triglycerides along with cholesteryl esters, free cholesterol, phospholipid, and proteins will be incorporated into chylomicron particles for release into the circulation via the lymphatic system and the thoracic duct.

    Cholesterol Synthesis

    Endogenous cholesterol synthesis contributes to the total body cholesterol concentration. Cholesterol can be synthesized by almost all cells, with the highest rate of synthesis in the liver and intestine (Turley et al., 1981). Approximately 1 g cholesterol per day is synthesized within the body from acetyl CoA. The enzyme 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCoA reductase) is the rate-limiting enzyme in cholesterol synthesis (Alberts, 1988).

    Lipoprotein Production

    Lipoproteins are the main carriers of triglycerides and cholesterol in the blood and are important in the delivery of cholesterol to all tissues. Circulating lipoproteins are classified by their size, density, and electrophoretic behavior (Mahley et al., 1974a). Lipoproteins in humans have been well characterized (Alaupovic et al., 1968; Assmann, 1982; Shepherd et al., 1989), but direct correlations cannot be made to the dog due to many differences in lipoprotein characteristics (Mahley et al., 1974a; Mahley et al., 1974b).

    Lipoproteins are micellar particles with a hydrophobic core containing triglycerides and cholesteryl esters, and an amphipathic outer surface containing phospholipid, unesterified cholesterol, and proteins (Assmann, 1982). Proteins within a lipoprotein tend to be specific for that lipoprotein class. Lipoprotein particles are not static, but are in a dynamic state of equilibrium, with transfer of components occurring between lipoproteins.

    Five major classes of lipoproteins have been characterized, including:

    • Chylomicrons
    • Very low density lipoproteins (VLDL)
    • Intermediate density lipoproteins (IDL)
    • Low density lipoproteins (LDL)
    • And high density lipoproteins (HDL).

    Some mammals (such as humans and most monkeys) have a predominance of LDL and are classified as "LDL mammals" (Chapman, 1986). LDL mammals are more sensitive to elevations in LDL cholesterol and the development of atherosclerosis. Dogs and most other mammals are considered "HDL mammals" due to the predominance of circulating HDL. HDL mammals are less sensitive to elevated LDL cholesterol concentrations, and are more resistant to the development of atherosclerosis (Table 1).

    Table 1. Predominance of Certain Lipoproteins by Species

    "LDL Mammals"  

    "HDL Mammals"  

    Humans and most Monkeys

    Dogs

    Rabbits

    Cats

    Hamsters

    Horses

    Guinea pigs

    Ruminants

    Pigs

    Rats

    Camels

    Mice

    Rhinoceros

    Most other mammals

    LDL: low density lipoproteins / HDL: high density lipoproteins

    In general, the larger lipoproteins are less dense, contain less protein, and more lipid. Chylomicrons are the largest of the lipoproteins with the lowest density. HDL are the smallest and heaviest of the lipoproteins. Characteristics of the individual lipoproteins are summarized in Table 2.

    Table 2. Canine Lipoprotein Characteristics

    Approximate Composition %

    Lipoprotein

    Hydrated Density

    g/mL

    Electro-phoretic Mobility

    Triglyceride

    Cholesteryl Ester

    Free Cholesterol

    Protein

    Phospholipid

    Major Apoproteins

    Chylomicron

    0.930

    Origin

    90

    2

    7

    2

    6

    B48', A, C, E

    VLDL

    <1.006

    β (preβ)

    60

    13

    7

    5

    15

    B100' B48

    LDL

    1.019 - 1.087

    β

    10

    38

    8

    22

    22

    B100

    HDL

    -

    -

    4

    16

    6

    50

    25

    -

    HDL1

    1.025 - 1.100

    α2

    -

    -

    -

    -

    -

    E, A, C

    HDL2

    1.063 - 1.100

    α1

    -

    -

    -

    -

    -

    A, C, E

    HDL3

    1.100 - 1.210

    α1

    -

    -

    -

    -

    -

    A, C

    In the peripheral circulation, chylomicrons gain apoprotein C and apoprotein E from HDL (Figure 2), increasing their protein content (Capurso, 1987). Lipoprotein lipase activated by apoprotein C-II of chylomicrons hydrolyzes the triglyceride present in chylomicrons, creating a phospholipid-rich particle. Lipoprotein lipase is associated with endothelial cell surfaces, interacting with membrane associated heparan sulfate (Nilsson-Ehle et al., 1980). Apoprotein A is transferred to HDL, and a chylomicron remnant is formed.

    Chylomicron metabolism
    Figure 2. Chylomicron metabolism. Chylomicron particles containing a high concentration of triglyceride are released from the intestinal mucosal cell into the lymphatics and to the circulation. Lipoprotein lipase hydrolysis of triglycerides within chylomicrons releases fatty acids and decreases the triglyceride content of chylomicrons, creating a chylomicron remnant. In addition, there is an exchange of apoproteins between HDL and chylomicrons. Chylomicrons contribute apoprotein A to HDL in exchange for apoproteins C and E. The chylomicron remnant formed is recognized by an apoprotein E receptor on hepatocytes and is removed from the circulation. A deficiency of lipoprotein lipase activity can result in decreased metabolism of chylomicrons to chylomicron remnants and thus a prolonged appearance of chylomicrons in the circulation.  

    Chylomicron remnant formation is necessary for hepatic clearance (Cooper, 1977). Once chylomicron remnants are formed, they are rapidly removed from the circulation by the apoprotein E receptor in liver cells (Mahley et al., 1989).

    VLDL are synthesized by hepatocytes (Figure 3), and are a major transporter of triglyceride (Mills et al., 1971). VLDL binds to lipoprotein lipase, and lipoprotein lipase hydrolyzes the triglyceride present in VLDL. This process may create VLDL remnants which can be removed by the liver via receptor or non-receptor-mediated uptake (Havel, 1984). HDL transfers apoprotein E to VLDL, creating an IDL particle. With further loss of triglyceride, phospholipid, and apoprotein, LDL is formed. Removal of LDL from the circulation is via the LDL receptor which binds both apoprotein B and apoprotein E (Goldstein et al., 1984).

    Chylomicron, VLDL, LDL, and liver cholesterol metabolism
    Figure 3. Chylomicron, VLDL, LDL, and liver cholesterol metabolism. Chylomicron particles containing lipids are released from the intestine into the circulation. Cholesterol-rich chylomicron remnants form and are recognized by the apoprotein E receptor on hepatocytes. Once in the hepatocyte, cholesterol can be stored as cholesteryl ester (via the action of ACAT), can be excreted into bile as cholesterol or bile acids, or secreted into VLDL particles. Synthesis of cholesterol in the hepatocyte (via HMGCoA reductase) contributes to the available cholesterol pool. Lipoprotein lipase hydrolysis of triglyceride within secreted VLDL and exchange of apoproteins create a triglyceride-depleted IDL which forms the triglyceride-poor, cholesterol-enriched LDL particle. The LDL receptor recognizes apoproteins B and E and mediates uptake and removal of LDL from the circulation. A deficiency of lipoprotein lipase activity can result in decreased metabolism of VLDL to LDL and thus a prolonged appearance of VLDL in the circulation.  

    Nascent HDL is secreted by the liver (Figure 4), and contains very little free cholesterol and cholesteryl ester. Free cholesterol is transferred from peripheral cells to nascent HDL, and these cholesterol- rich particles serve as substrate for lecithin:cholesterol acyltransferase (LCAT), converting free cholesterol to cholesteryl esters. With the increased concentration of cholesteryl esters, the core of HDL enlarges and becomes more spherical. Hepatic lipase may also play a role in the interconversion of HDL subfractions (Groot et al., 1981). The conversion of free cholesterol to cholesteryl esters and its subsequent transfer to other lipoproteins allows additional free cholesterol to transfer from the surface of cells and other lipoproteins to HDL (Kostner et al., 1987). Thus LCAT plays a key role in the transfer of free cholesterol from peripheral tissues to the liver (Albers et al., 1986).

    Reverse cholesterol transport
    Figure 4. Reverse cholesterol transport. Discoidal HDL (nascent HDL) is secreted by the liver and obtains unesterified cholesterol from peripheral cells. LCAT in the circulation esterifies this cholesterol, resulting in a more spherical cholesteryl ester-rich particle. If cholesteryl ester transfer protein (CETP) is present, cholesteryl ester is transferred from HDL to LDL, with exchange of triglyceride from LDL to HDL. LDL carrying cholesteryl ester derived from peripheral cells returns to the liver completing reverse cholesterol transport. In dogs with little CETP, other mechanisms exist to return cholesterol to the liver via HDL directly.  

    In humans, cholesteryl ester transfer protein (CETP) is responsible for cholesteryl ester and triglyceride exchange between HDL and LDL or VLDL. Cholesteryl ester derived from free cholesterol in peripheral cells is transferred to LDL, which can then return to the liver via receptormediated uptake (reverse cholesterol transport) (Noel et al., 1984). Dogs however have low levels of CETP (Mahley et al., 1983); thus there is little transfer of cholesteryl ester to LDL. Without cholesteryl ester transfer, HDL remains enriched with cholesteryl esters, and is designated HDL1, or HDLc. In the dog, reverse cholesterol transport is completed via HDL uptake by the liver. The dog is a "HDL mammal" since most of the circulating cholesterol is carried by HDL and cannot be transferred to LDL as in humans (an "LDL mammal").

    Back to Table of Contents
    Add to My Library
    Close
    Would you like to add this to your library?

    Get access to all handy features included in the IVIS website

    • Get unlimited access to books, proceedings and journals.
    • Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
    • Bookmark your favorite articles in My Library for future reading.
    • Save future meetings and courses in My Calendar and My e-Learning.
    • Ask authors questions and read what others have to say.
    Sign in Register
    Print this article
    References

    1. Adan Y, Shibata K, Sato M et al. Effects of docosahexaenoic and eicosapentaenoic acid on lipid metabolism, eicosanoid production, platelet aggregation and atherosclerosis in hypercholesterolemic rats. Biosci Biotechnol Biochem 1999; 63(1):111-9.

    ...
    Show all
    Comments (0)

    Ask the author

    0 comments
    Submit
    Close
    Would to like to further discuss this item?

    Get access to all handy features included in the IVIS website

    • Get unlimited access to books, proceedings and journals.
    • Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
    • Bookmark your favorite articles in My Library for future reading.
    • Save future meetings and courses in My Calendar and My e-Learning.
    • Ask authors questions and read what others have to say.
    Sign in Register
    About

    How to reference this publication (Harvard system)?

    Schenck, P. A. (2008) “Lipid Metabolism”, Encyclopedia of Canine Clinical Nutrition. Available at: https://www.ivis.org/library/encyclopedia-of-canine-clinical-nutrition/lipid-metabolism (Accessed: 28 January 2023).

    Affiliation of the authors at the time of publication

    College of Veterinary Medicine, Michigan State University, MI, USA.

    Author(s)

    • Schenck P.A.

      DVM MA PhD
      Department of Pathobiology and Diagnostic Investigation, College of Veterinary Medicine, Michigan State University
      Read more about this author

    Copyright Statement

    © All text and images in this publication are copyright protected and cannot be reproduced or copied in any way.
    Related Content

    Readers also viewed these publications

    • Journal Issue

      Veterinary Evidence - Vol 8 N°1, Jan-Mar 2023

      In: Veterinary Evidence
      JAN 28, 2023
    • Journal Issue

      Veterinary Evidence - Vol 7 N°4, Oct-Dec 2022

      In: Veterinary Evidence
      JAN 16, 2023
    • Proceeding

      SFT - Theriogenology Annual Conference - Bellevue, 2022

      By: Society for Theriogenology
      JAN 10, 2023
    • Journal Issue

      Urgencias y cuidados intensivos - Argos N°244, Diciembre 2022

      In: Argos
      DEC 31, 2022
    • Proceeding

      ISCFR-EVSSAR Symposium - Italy 2022

      By: International Symposium on Canine and Feline Reproduction
      DEC 02, 2022
    • Journal Issue

      Patología endocrina - Argos N°243, Noviembre 2022

      In: Argos
      NOV 27, 2022
    • Journal Issue

      Traumatología y neurología - Argos Nº242, Octubre 2022

      In: Argos
      NOV 10, 2022
    • Chapter

      Tibia and Tarsus

      In: Current Techniques in Small Animal Surgery (5th Edition)
      NOV 07, 2022
    • Chapter

      Femur and Stifle Joint

      In: Current Techniques in Small Animal Surgery (5th Edition)
      OCT 28, 2022
    • Journal Issue

      Medicina felina - Argos Nº241, Septiembre 2022

      In: Argos
      OCT 24, 2022
    • Chapter

      Sacroiliac Joint, Pelvis, and Hip Joint

      In: Current Techniques in Small Animal Surgery (5th Edition)
      OCT 17, 2022
    • Journal Issue

      Veterinary Evidence - Vol 7 N°2, Apr-Jun 2022

      In: Veterinary Evidence
      OCT 07, 2022
    • Journal Issue

      Veterinary Evidence - Vol 7 N°3, Jul-Sep 2022

      In: Veterinary Evidence
      OCT 04, 2022
    • Chapter

      Amputation of the Forelimb

      In: Current Techniques in Small Animal Surgery (5th Edition)
      OCT 02, 2022
    • Journal Issue

      Israel Journal of Veterinary Medicine - Vol. 77(3), Sep. 2022

      In: Israel Journal of Veterinary Medicine
      SEP 30, 2022
    • Chapter

      Carpus, Metacarpus, and Phalanges

      In: Current Techniques in Small Animal Surgery (5th Edition)
      SEP 26, 2022
    • Chapter

      Radius and Ulna

      In: Current Techniques in Small Animal Surgery (5th Edition)
      SEP 16, 2022
    • Chapter

      Humerus and Elbow Joint

      In: Current Techniques in Small Animal Surgery (5th Edition)
      SEP 10, 2022
    • Chapter

      Scapula and Shoulder Joint

      In: Current Techniques in Small Animal Surgery (5th Edition)
      SEP 05, 2022
    • Chapter

      Bone Grafts and Implants

      In: Current Techniques in Small Animal Surgery (5th Edition)
      SEP 03, 2022
    • Chapter

      External Skeletal Fixation

      In: Current Techniques in Small Animal Surgery (5th Edition)
      AUG 28, 2022
    • Chapter

      Plate-Rod Fixation

      In: Current Techniques in Small Animal Surgery (5th Edition)
      AUG 18, 2022
    • Chapter

      Fixation with Screws and Bone Plates

      In: Current Techniques in Small Animal Surgery (5th Edition)
      AUG 15, 2022
    • Journal Issue

      Israel Journal of Veterinary Medicine - Vol. 77(2), Jun. 2022

      In: Israel Journal of Veterinary Medicine
      AUG 12, 2022
    • Chapter

      Interlocking Nailing of Canine and Feline Fractures

      In: Current Techniques in Small Animal Surgery (5th Edition)
      AUG 11, 2022
    • Load more
    Back To Top
    Become a member of IVIS and get access to all our resources
    Create an account
    Sign in
    Leading the way in providing veterinary information
    About IVIS
    • Mission
    • What we do
    • Who we are
    Need help?
    • Contact
    Follow IVIS
    • Twitter
    • Facebook
    International Veterinary Information Service (IVIS) is a not-for-profit organization established to provide information to veterinarians, veterinary students, technicians and animal health professionals worldwide using Internet technology.
    Support IVIS
    © 2023 International Veterinary Information Service
    • Disclaimer
    • Privacy Policy